Analytical Data
-
Gene name
LY6G5B
- Application
-
Alternative Names
LY6G5B; C6orf19; G5B; Lymphocyte antigen 6 complex locus protein G5b
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8NDX9
-
Expression Region
1-201aa
-
AA Sequence
MKVHMLVGVLVMVGFTVGKVPVPDIRTCHFCLVEDPSVGCISGSEKCTISSSSLCMVITIYYDVKVRFIVRGCGQYISYRCQEKRNTYFAEYWYQAQCCQYDYCNSWSSPQLQSSLPEPHDRPLALPLSDSQIQWFYQALNLSLPLPNFHAGTEPDGLDPMVTLSLNLGLSFAELRRMYLFLNSSGLLVLPQAGLLTPHPS
-
Molecular Weight
49 KDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LY6G5B is a member of the Ly-6 family of proteins, which are known for their role in immune response regulation and cell signaling. Research on LY6G5B has gained attention due to its potential involvement in various biological processes, including T cell activation and differentiation. The protein is predominantly expressed in immune cells, suggesting that it may play a crucial role in modulating immune responses and maintaining homeostasis. Initial studies indicate that LY6G5B could have implications in autoimmune diseases and cancer by influencing the proliferation and function of lymphocytes. Understanding the structure and function of LY6G5B can provide insights into its mechanism of action and its therapeutic potential. Furthermore, the recombinant expression of LY6G5B in a laboratory setting allows for detailed biochemical and biophysical characterization, paving the way for future studies to explore its role in immunotherapy and vaccine development. Given the rise in immune-related conditions, elucidating the functions of LY6G5B could offer new avenues for targeted therapies, underscoring the importance of continued research in this area.











